Teva Pharmaceutical (Israel) Investor Sentiment

TEVA Stock  ILA 6,400  385.00  5.67%   
About 62% of Teva Pharmaceutical's investor base is looking to short. The analysis of current outlook of investing in Teva Pharmaceutical Industries suggests that many traders are alarmed regarding Teva Pharmaceutical's prospects. The current market sentiment, together with Teva Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
  
3 days ago at news.google.com         
TEVA Stock Down 14 percent Despite Q4 Earnings Revenues Beat Estimates - Yahoo Finance
Google News at Macroaxis
few days ago at news.google.com         
Teva Pharmaceutical Industries Q4 2024 Earnings Call Transcript - AOL
Google News at Macroaxis
over two weeks ago at news.google.com         
Hennessy Advisors Inc. Has 16.01 Million Stock Position in Teva Pharmaceutical Industries Limited - ...
Google News at Macroaxis
over two weeks ago at news.google.com         
Teva sues CMS over Medicare drug price negotiations - Seeking Alpha
Google News at Macroaxis
over two weeks ago at news.google.com         
Theres No Escaping Teva Pharmaceutical Industries Limiteds Muted Revenues Despite A 27 percent Share...
Google News at Macroaxis
over three weeks ago at news.google.com         
Teva Pharmaceutical Industries Shares Pass Above 200-Day Moving Average - Heres What Happened - Mark...
Google News at Macroaxis
over a month ago at news.google.com         
TEVA - Teva Pharmaceutical Industries Limited American Depositary Shares Latest Stock News Market Up...
Google News at Macroaxis
over a month ago at news.google.com         
Teva Pharmaceutical Industries Limited A Bull Case Theory - Yahoo Finance
Google News at Macroaxis
over a month ago at news.google.com         
Teva Pharmaceutical Industries Limited Shares Acquired by Barclays PLC - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Strength Seen in Teva Pharmaceutical Industries Can Its 26.5 percent Jump Turn into More Strength - ...
Google News at Macroaxis
over a month ago at news.google.com         
TEVA stock soars to 52-week high, reaches 19.92 - Investing.com
Google News at Macroaxis
over a month ago at news.google.com         
State Street Corp Increases Stake in Teva Pharmaceutical Industries Limited - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Teva Pharmaceutical to Exit Generic Drug Business in Japan Through Strategic Divestment TEVA Stock N...
Google News at Macroaxis
over a month ago at news.google.com         
Teva Pharmaceutical Industries Ltd Shares Up 3.14 percent on Dec 4 - GuruFocus.com
Google News at Macroaxis
over two months ago at news.google.com         
BofA sees Teva shares on track for re-rate with solid bridge to low-DD percent financial targets - I...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Teva Pharmaceutical that are available to investors today. That information is available publicly through Teva media outlets and privately through word of mouth or via Teva internal channels. However, regardless of the origin, that massive amount of Teva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Teva Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Teva Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Teva Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Teva Pharmaceutical alpha.

Teva Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Stocks Directory
Find actively traded stocks across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets